CB1 receptor deficiency decreases wheel-running activity: Consequences on emotional behaviours and hippocampal neurogenesis

Experimental Neurology

Volumn 224, Issue 1, 2010, Pages 106-113

  Dubreucq, Sarah ^a,b   Koehl, Muriel ^a,b   Abrous, Djoher N ^a,b   Marsicano, Giovanni ^a,b   Chaouloff, Francis ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

CB1 knockout; CB1 receptor; Endocannabinoids; Fear memory; Forced swim immobility; Locomotor reactivity; Mice; Neurogenesis; Running behaviour; Wheel running

Indexed keywords

CANNABINOID 1 RECEPTOR; DOUBLECORTIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL HOUSING; ARTICLE; ASSOCIATION; AVERSIVE BEHAVIOR; CELL MATURATION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; EMOTIONALITY; EXPLORATORY BEHAVIOR; FEAR; FORCED SWIMMING TEST; GENOTYPE; HIPPOCAMPUS; IMMOBILIZATION; LIGHT DARK CYCLE; LOCOMOTION; MEMORY CONSOLIDATION; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OPEN FIELD BEHAVIOR; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RUNNING; TIME; VELOCITY; VOLUNTARY MOVEMENT; WILD TYPE;

EID: 77953707757     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.01.017     Document Type: Article

References (66)

1. Aguado T., Palazuelos J., Monory K., Stella N., Cravatt B., Lutz B., Marsicano G., Kokaia Z., Guzmán M., Galve-Roperh I. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J. Neurosci. 2006, 26:1551-1561.
2. Alger E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 2002, 68:247-286.
3. Burghardt P.R., Pasumarthi R.K., Wilson M.A., Fadel J. Alterations in fear conditioning and amygdalar activation following chronic wheel running. Pharmacol. Biochem. Behav. 2006, 84:306-312.
4. Cannich A., Wotjak C.T., Kamprath K., Hermann H., Lutz B., Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learn. Mem. 2004, 11:625-632.
5. Chaouloff F. Physical exercise and brain monoamines: a review. Acta Physiol. Scand. 1989, 137:1-13.
6. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 2006, 29:37-76.
7. Cota D., Marsicano G., Tschöp M., Grübler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thöne-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A.C., Pasquali R., Lutz B., Stalla G.K., Pagotto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 2003, 112:423-431.
8. Cotman C.W., Berchtold N.C., Christie L.A. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 2007, 30:464-472.
9. De Chiara V., Errico F., Musella A., Rossi S., Mataluni G., Sacchetti L., Siracusano A., Castelli M., Cavasinni F., Bernardi G., Usiello A., Centonze D. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology 2009, 35:374-387.
10. Dietrich A., McDaniel W.F. Endocannabinoids and exercise. Br. J. Sports Med. 2004, 38:536-541.
11. Droste S.K., Gesing A., Ulbricht S., Müller M.B., Linthorst A.C., Reul J.M. Effects of long-term voluntary exercise on the mouse hypothalamic-pituitary-adrenocortical axis. Endocrinology 2003, 144:3012-3023.
12. Dubreucq, S., Marsicano, G., Chaouloff, F., 2010. Emotional consequences of wheel running in mice: which is the appropriate control? Hippocampus (in press).
13. Duman C., Schlesinger L., Russell D.S., Duman R.S. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res. 2008, 199:148-158.
14. Fediuc S., Campbell J.E., Riddell M.C. Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats. J. Appl. Physiol. 2006, 100:1867-1875.
15. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
16. Fuss J., Ben Abdallah N.M.B., Vogt M.A., Touma C., Pacifici P.G., Palme R., Witzemann V., Hellweg R., Gass P. Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus 2010, 20:364-376.
17. Greenwood B.N., Foley T.E., Day H.E.W., Campisi J., Hammack S.H., Campeau S., Maier S.F., Fleshner M. Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J. Neurosci. 2003, 23:2889-2898.
18. Greenwood B.N., Strong P.V., Foley T.E., Fleshner M. A behavioral analysis of the impact of voluntary physical activity on hippocampus-dependent contextual conditioning. Hippocampus 2009, 19:988-1001.
19. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:1932-1936.
20. Hill, M.N., Titterness, A.K., Morrish, A.C., Carrier, E.J., Lee, T.T., Gil-Mohapel, J., Gorzalka, B.B., Hillard, C.J., Christie, B.R., 2009. Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus (in press).
21. Hillman C.H., Erickson K.I., Kramer A.F. Be smart, exercise your heart: exercise effects on brain and cognition. Nat. Rev. Neurosci. 2008, 9:58-65.
22. Hoffmann P. The endorphin hypothesis. Physical Activity & Mental Health 1997, 163-177. Taylor & Francis, Washington. W.P. Morgan (Ed.).
23. Holmes P.V. Rodent models of depression: reexamining validity without anthropomorphic inference. Crit. Rev. Neurobiol. 2003, 15:143-174.
24. Holmes M.M., Galea L.A.M., Mistlberger R.E., Kempermann G. Adult hippocampal neurogenesis and voluntary wheel running activity: circadian and dose-dependent effects. J. Neurosci. Res. 2004, 76:216-222.
25. Jin K., Xie L., Kim S.H., Parmentier-Batteur S., Sun Y., Mao X.O., Childs J., Greenberg D.A. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol. Pharmacol. 2004, 66:204-208.
26. Katona I., Sperlagh B., Ski A., Käfalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 receptors regulate GABA release from axon terminals of specific hippocampal interneurones. J. Neurosci. 1999, 19:4544-4558.
27. Jacob W., Yassouridis A., Marsicano G., Monory K., Lutz B., Wotjak C.T. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav. 2009, 8:685-698.
28. Jiang W., Zhang Y., Xiao L., Van Cleemput J., Ji S.P., Bai G., Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J. Clin. Invest. 2005, 115:3104-3116.
29. Kamprath K., Marsicano G., Tang J., Monory K., Bisogno T., Di Marzo V., Lutz B., Wotjak C.T. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J. Neurosci. 2006, 26:6677-6686.
30. Keeney B.K., Raichlen D.A., Meek T.H., Wijeratne R.S., Middleton K.M., Gerdeman G.L., Garland T. Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour. Behav. Pharmacol. 2008, 19:812-820.
31. Koehl M., Meerlo P., Gonzales D., Rontal A., Turek F.W., Abrous D.N. Exercise-induced promotion of hippocampal cell proliferation requires beta-endorphin. FASEB J. 2008, 22:2253-2262.
32. Koteja P., Garland T., Sax J.K., Swallow J.G., Carter P.A. Behaviour of house mice artificially selected for high levels of voluntary wheel running. Anim. Behav. 1999, 58:1307-1318.
33. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.-F., Beslot F., Böhme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283:401-404.
34. Lemaire V., Koehl M., Le Moal M., Abrous D.N. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11032-11037.
35. Lett B.T., Grant V.L., Byrne M.J., Koh M.T. Pairings of a distinctive chamber with the aftereffect of wheel running produce conditioned place preference. Appetite 2000, 34:87-94.
36. Maldonado R., Valverde O., Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006, 29:225-232.
37. Maren S. Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur. J. NeuroSci. 2008, 28:1661-1666.
38. Maren S., Quirk G.J. Neuronal signalling of fear memory. Nat. Rev. Neurosci. 2004, 5:844-852.
39. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. NeuroSci. 1999, 11:4213-4225.
40. Marsicano G., Lutz B. Neuromodulatory functions of the endocannabinoid system. J. Endocrinol. Invest. 2006, 29:27-46.
41. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., López-Rodriguez M.L., Casanova E., Schütz G., Zieglgänsberger W., Di Marzo V., Behl C., Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84-88.
42. Marsicano G., Wotjak C.T., Azad S., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgänsberger W., Di Marzo V., Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
43. Martinsen E.W., Morgan W.P. Antidepressant effects of physical activity. Physical Activity & Mental Health 1997, 93-106. Taylor & Francis, Washington. W.P. Morgan (Ed.).
44. Meeusen R., Piacentini M.F., De Meirleir K. Brain microdialysis in exercise research. Sports Med. 2001, 31:965-983.
45. 9-tetrahydrocannabinol in mice. PLoS-Biol. 2007, 5:e269.
46. Pacher P., Bátkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006, 58:389-462.
47. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 1992, 106:274-285.
48. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4:873-884.
49. Raglin J.S. Anxiolytic effects of physical activity. Physical Activity & Mental Health 1997, 107-126. Taylor & Francis, Washington. W.P. Morgan (Ed.).
50. Ramos A., Berton A., Mormède P., Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav. Brain Res. 1997, 85:57-69.
51. Ramos A., Mormède P. Stress and emotionality: a multidimensional and genetic approach. Neurosci. Biobehav. Rev. 1998, 22:33-57.
52. Salam J.N., Fox J.H., Detroy E.M., Guignon M.H., Wohl D.F., Falls W.A. Voluntary exercise in C57 mice is anxiolytic across several measures of anxiety. Behav. Brain Res. 2009, 197:31-40.
53. Salmon P. Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Clin. Psychol. Rev. 2001, 21:33-61.
54. Shearman L.P., Rosko K.M., Fleischer R., Wang J., Xu S., Tong X.S., Rocha B.A. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav. Pharmacol. 2003, 14:573-582.
55. Sherwin C.M. Voluntary wheel running: a review and novel interpretation. Anim. Behav. 1998, 56:11-27.
56. Sparling P.B., Giuffrida A., Piomelli D., Rosskopf L., Dietrich A. Exercise activates the endocannabinoid system. NeuroReport 2003, 14:2209-2211.
57. Steiner M.A., Wotjak C.T. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog. Brain Res. 2008, 170:397-432.
58. Steiner M.A., Marsicano G., Nestler E.J., Holsboer F., Lutz B., Wotjak C.T. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 2008, 33:54-67.
59. Steiner M.A., Wanisch K., Monory K., Marsicano G., Borroni E., Bächli H., Holsboer F., Lutz B., Wotjak C.T. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 2008, 8:196-208.
60. Urigüen L., Pérez-Rial S., Ledent C., Palomo T., Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 2004, 46:966-973.
61. van Praag H. Exercise and the brain: something to chew on. Trends Neurosci. 2009, 32:283-290.
62. van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 1999, 2:266-270.
63. de Visser L., van den Bos R., Spruijt B.M. Automated home cage observations as a tool to measure the effects of wheel running on cage floor locomotion. Behav. Brain Res. 2005, 160:382-388.
64. Werme M., Messer C., Olson L., Gilden L., Thorén P., Nestler E.J., Brene S. Delta FosB regulates wheel running. J. Neurosci. 2002, 22:8133-8138.
65. Yoo H.S., Bunnell B.N., Crabbe J.B., Kalish L.R., Dishman R.K. Failure of neonatal clomipramine treatment to alter forced swim immobility: chronic treadmill or activity-wheel running and imipramine. Physiol. Behav. 2000, 70:407-411.
66. Zhou D., Shearman L.P. Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacol. Biochem. Behav. 2004, 77:117-125.